Protara Therapeutics, Inc.

NASDAQ:TARA

2.59 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q3
Revenue 001.2080000000000000000000000000000000000002.948
Cost of Revenue 0.0830.0830.1070.1070.420.0770.0740.0640.3950.397000.0550.03200000000000000000000000000
Gross Profit -0.083-0.0831.101-0.107-0.42-0.077-0.074-0.064-0.395-0.39700-0.055-0.03200000000000000000000000002.948
Gross Profit Ratio 000.9110000000000000000000000000000000000001
Reseach & Development Expenses 6.3047.6656.3816.2187.2475.1434.9893.4663.0845.2694.0684.0935.8877.043.6512.7962.473.065-3.1851.0990.9871.0781.1092.3542.764.073.2110.343.894.254.444.845.244.353.583.083.092.631.871.773
General & Administrative Expenses 4.2744.1034.664.4824.8934.5895.0034.5085.6215.6056.2196.7376.9056.545.3055.2664.7967.0950.631.2550.4420.450.2982.2682.242.292.381.972.12.232.432.322.612.472.6121.891.991.41.041
Selling & Marketing Expenses 04.099-0.10700000000000000000000000.01000000.0100000000
SG&A 4.2744.1034.5534.4824.8934.5895.0034.5085.6215.6056.2196.7376.9056.545.3055.2664.7967.0950.631.2550.4420.450.2982.2682.242.32.381.972.12.232.432.332.612.472.6121.891.991.41.041
Other Expenses 00000029.517000000000000000000000000000000000
Operating Expenses 10.57811.76810.93410.712.149.7329.9927.9748.70510.87410.28710.8312.79213.588.9568.0627.26610.16-2.5552.3541.4291.5281.4074.62256.375.5912.315.996.486.877.177.856.826.195.084.984.623.272.814
Operating Income -10.661-11.851-11.041-10.7-12.14-9.73220.474-7.974-8.705-10.874-10.287-10.83-12.792-13.58-8.956-8.062-7.266-10.162.555-2.354-1.429-1.528-1.407-4.622-5-6.37-5.59-12.31-5.99-6.48-6.87-7.17-7.85-6.82-6.19-5.08-4.98-4.62-3.270.134
Operating Income Ratio 00-9.140000000000000000000000000000000000000.045
Total Other Income Expenses Net 1.1480.7560.820.840.0040.687-59.440.2830.1660.1190.0590.0530.010.1150.1490.0920.1260.0990.030.818-3.8860.1060.1260.1120.120.290.04-6.7480.38-0.02-0.090.06-0.060.27-0.15-0.3-0.090.0410.5-7.592
Income Before Tax -9.513-11.095-10.221-9.86-11.294-9.045-38.966-7.691-8.539-10.755-10.228-10.777-12.782-13.465-8.808-7.97-7.14-10.062.585-2.354-1.429-1.528-1.407-4.51-4.88-6.08-5.55-12.31-5.61-6.5-6.96-7.11-7.91-6.55-6.34-5.38-5.07-4.587.23-7.458
Income Before Tax Ratio 00-8.461000000000000000000000000000000000000-2.53
Income Tax Expense 00.041.64-0.107-0.846-0.687-0.107-0.283-0.346-0.1191.9740.0240000.0210.02-0-0.0310.735-3.9080.2110.2510.2250.230.380.14-6.6680.430.01-0.050.11-0.010.33-0.12-0.27-0.050.0810.5130
Net Income -9.513-11.095-10.221-9.86-11.294-8.358-38.859-7.408-8.193-10.636-10.228-10.777-12.782-13.465-8.808-7.97-7.14-10.062.585-2.354-1.429-1.528-1.407-4.51-4.88-6.08-5.55-12.31-5.61-6.5-6.96-7.11-7.91-6.55-6.34-5.38-5.07-4.587.23-7.458
Net Income Ratio 00-8.461000000000000000000000000000000000000-2.53
EPS -0.45-0.97-0.9-0.87-1-0.74-3.45-0.66-0.73-0.95-0.91-0.96-1.14-1.2-0.79-1.26-1.22-1.81-0.29-0.92-0.56-0.58-0.12-10.12-11.09-13.82-12.61-27.98-13.05-15.48-16.98-17.34-19.29-15.98-15.46-13.12-12.37-11.1723.32-31.03
EPS Diluted -0.45-0.97-0.9-0.87-1-0.74-3.45-0.66-0.73-0.95-0.91-0.96-1.14-1.2-0.78-1.26-1.22-1.81-0.29-0.92-0.56-0.58-0.12-10.12-11.09-13.82-12.61-27.98-13.05-15.48-16.98-17.34-19.29-15.98-15.46-13.12-12.37-11.1723.32-31.03
EBITDA -10.578-11.768-10.934-10.7-12.066-9.73219.525-6.329-8.14-10.289-8.259-10.83-12.737-13.548-8.892-8.014-7.252-10.092.803-2.354-1.429-6.252-5.102-4.374-4.74-5.96-5.42-12.19-5.52-6.43-6.89-7.02-7.83-6.47-6.28-5.34-5.02-4.537.2530.134
EBITDA Ratio 00-9.0510000000000000000000000000000000000000.045